Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc201179.pdf
Reference4 articles.
1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005a) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687–1717
2. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005b) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087–2106
3. Fibrinolytic Therapy Trialists’ Collaborative Group (FTT) (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343: 311–322
4. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 332: 349–360
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Illustrative Case of Aspirin: Making Sense of Evidence When Weighing Risk and Benefit;The Senior Care Pharmacist;2024-06-01
2. Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-Analysis;Cancers;2024-05-30
3. Iterative Causal Forest: A Novel Algorithm for Subgroup Identification;American Journal of Epidemiology;2023-11-07
4. Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview;Diabetes & Metabolism Journal;2023-09-30
5. Epistemological Pitfalls in the Proxy Theory of Race: The Case of Genomics-Based Medicine ;The British Journal for the Philosophy of Science;2023-09-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3